WisdomTree Insights

When forecasting, there is a bias to overestimate the short term, but underestimate the long term, especially with exponential topics like AI. Christopher Gannatti takes a look at five major companies and evaluates their AI journeys so far in 2024. 
Read the article
The world is telling us that we are in the midst of an artificial intelligence revolution. Christopher Gannatti takes a deep dive into two of our Funds that can capture the growth and innovation potential of the AI landscape and compares them to Invesco QQQ. 
Read the article
Generative AI is not just for making fake celebrity photos. It can also help us design better buildings, batteries and solutions for the world’s challenges. Christopher Gannatti takes a look at technological revolutions of the past, the need for discipline in the AI space and investment opportunities.  
Read the article
Bill Gates recently posed five questions about AI and its potential to improve innovation in healthcare in his annual letter. Christopher Gannatti takes a look at each question and then highlights a WisdomTree strategy that focuses on the biotechnology sphere.
Read the article
Biotech stocks have been underperforming for three years, but could a recent breakthrough in CRISPR therapy change the tide? Christopher Gannatti explores potential opportunities and how to invest. 
Read the article
Cybersecurity is not a luxury; it’s a necessity. Christopher Gannatti discusses how the rising perception of risk is coinciding with rising revenues at cybersecurity companies.
Read the article